These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2205423)

  • 21. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic profiles and lipoprotein lipid concentrations in non-obese and obese patients with polycystic ovarian disease.
    Mahabeer S; Naidoo C; Norman RJ; Jialal I; Reddi K; Joubert SM
    Horm Metab Res; 1990 Oct; 22(10):537-40. PubMed ID: 2079317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin as a factor of increased androgen production in women with obesity and polycystic ovaries.
    Pasquali R; Antenucci D; Casimirri F; Venturoli S; Paradisi R; Fabbri R; Melchionda N; Barbara L
    J Endocrinol Invest; 1987 Dec; 10(6):575-9. PubMed ID: 3326891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polycystic ovaries and associated metabolic abnormalities in Indian subcontinent Asian women.
    Rodin DA; Bano G; Bland JM; Taylor K; Nussey SS
    Clin Endocrinol (Oxf); 1998 Jul; 49(1):91-9. PubMed ID: 9797852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of plasma insulin and insulin-like growth factor-I with indices of androgen transport and metabolism in women with polycystic ovary syndrome.
    Sharp PS; Kiddy DS; Reed MJ; Anyaoku V; Johnston DG; Franks S
    Clin Endocrinol (Oxf); 1991 Sep; 35(3):253-7. PubMed ID: 1742883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endocrine abnormalities in ovulatory women with polycystic ovaries on ultrasound.
    Carmina E; Wong L; Chang L; Paulson RJ; Sauer MV; Stanczyk FZ; Lobo RA
    Hum Reprod; 1997 May; 12(5):905-9. PubMed ID: 9194637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin resistance in patients with polycystic ovaries: its relationship to body weight and androgen levels.
    Pasquali R; Casimirri F; Venturoli S; Paradisi R; Mattioli L; Capelli M; Melchionda N; Labò G
    Acta Endocrinol (Copenh); 1983 Sep; 104(1):110-6. PubMed ID: 6137924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subclinical impairment of left ventricular function in young obese women: contributions of polycystic ovary disease and insulin resistance.
    Kosmala W; O'Moore-Sullivan TM; Plaksej R; Kuliczkowska-Plaksej J; Przewlocka-Kosmala M; Marwick TH
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3748-54. PubMed ID: 18682502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum lipids and lipoproteins in women with polycystic ovarian disease with different body mass index.
    Rojanasakul A; Chailurkit L; Sirimongkolkasem R; Chaturachinda K
    Int J Gynaecol Obstet; 1988 Dec; 27(3):401-6. PubMed ID: 2904906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucagon in women with polycystic ovary syndrome (PCO): relationship to abnormalities of insulin and androgens.
    Golland IM; Vaughan Williams CA; Shalet SM; Laing I; Elstein M
    Clin Endocrinol (Oxf); 1990 Nov; 33(5):645-51. PubMed ID: 2147602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An abnormality of the growth hormone/insulin-like growth factor-I axis in women with polycystic ovary syndrome due to coexistent obesity.
    Slowinska-Srzednicka J; Zgliczynski W; Makowska A; Jeske W; Brzezinska A; Soszynski P; Zgliczynski S
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1432-5. PubMed ID: 1534330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Insulin resistance and serum concentrations of ovarian and adrenal androgen in obese women without additional disease and with policystic ovary syndrome].
    Olszanecka-Glinianowicz M; Banaś M; Zahorska-Markiewicz B; Kuglin D; Mokrzycka J; Mentel A
    Endokrynol Pol; 2005; 56(6):921-6. PubMed ID: 16821212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels.
    Piouka A; Farmakiotis D; Katsikis I; Macut D; Gerou S; Panidis D
    Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E238-43. PubMed ID: 18957615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum leptin levels in premature pubarche and prepubertal girls with and without obesity.
    Teixeira RJ; Ginzbarg D; Rodrigues Freitas J; Fucks G; Silva CM; Bordallo MA
    J Pediatr Endocrinol Metab; 2004 Oct; 17(10):1393-8. PubMed ID: 15526717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome.
    Holte J; Bergh T; Berne C; Wide L; Lithell H
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2586-93. PubMed ID: 7673399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gonadotrophin and gonadal steroid response to a single dose of a long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome.
    White D; Leigh A; Wilson C; Donaldson A; Franks S
    Clin Endocrinol (Oxf); 1995 May; 42(5):475-81. PubMed ID: 7621565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relative contribution of androgens and insulin in determining abdominal body fat distribution in premenopausal women.
    Pasquali R; Casimirri F; Balestra V; Flamia R; Melchionda N; Fabbri R; Barbara L
    J Endocrinol Invest; 1991 Nov; 14(10):839-46. PubMed ID: 1802922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study.
    Panidis D; Tziomalos K; Misichronis G; Papadakis E; Betsas G; Katsikis I; Macut D
    Hum Reprod; 2012 Feb; 27(2):541-9. PubMed ID: 22144419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of linear relationship between hyperinsulinaemia and hyperandrogenism.
    Toscano V; Bianchi P; Balducci R; Guglielmi R; Mangiantini A; Lubrano C; Sciarra F
    Clin Endocrinol (Oxf); 1992 Feb; 36(2):197-202. PubMed ID: 1533185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.